DocMorris AG (VTX:DOCM) shareholders should be happy to see the share price up 10% in the last month. But the last three years have seen a terrible decline. To wit, the share price sky-dived 90% in ...

Gleichzeitig spricht sich der Stimmrechtsberater gegen die vom polnischen Grossaktionär CEPD vorgeschlagenen Kandidaten aus.

Algolia announces its partnership with DocMorris, a leading online pharmacy, telemedicine and professional healthcare company.

Sales of prescription medicines (Rx) grew year-on-year in July Monthly number of new Rx customers quadrupled Break-even achieved excluding eRx in the first half of 2024 Outlook 2024 reduced CardLink ...

Zürich, 28. Apr (Reuters) - Im Machtkampf um die Führung der Online-Apotheke DocMorris stellt sich der Stimmrechtsberater Institutional Shareholder Services (ISS) auf die Seite des bestehenden Managem ...

Tripling of new Rx customers since the introduction of CardLink Doubling and continuous increase in eRx market share since January 2024 17 per cent revenue growth of prescription medicines (Rx) ...

Good morning, everyone, and welcome to our Q1 '26 trading update. I'm Walter Hess, the CEO, and I'm joined today by our CFO, Daniel Wuest. In line with what we announced at the full year conference, ...

Aug 17 (Reuters) - Swiss online drug retailer DocMorris (DOCM.S), opens new tab on Thursday reported a first-half adjusted core loss roughly in line with expectations, a result boosted by the ...

(Reuters) -Swiss online drug retailer DocMorris AG could make a core loss of up to 35 million Swiss francs ($39.6 million) in 2024, it said on Thursday, warning growth in its prescription business in ...

DocMorris AG (SIX:DOCM) on Thursday reported first-quarter revenue growth of 10.7% in local currency, reaching CHF318.1m. The Swiss online pharmacy’s prescripti ...

Good morning, everybody, and thank you for joining today's conference call, which will be hosted by Daniel Wüest, our CFO, and me. Let me start by giving you a quick overview of the key highlights ...